ketanserin has been researched along with Diabetic Retinopathy in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pietraszek, MH | 1 |
| Takada, Y | 1 |
| Takada, A | 1 |
| Fujita, M | 1 |
| Watanabe, I | 1 |
| Taminato, A | 1 |
| Yoshimi, T | 1 |
1 other study available for ketanserin and Diabetic Retinopathy
| Article | Year |
|---|---|
Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Adult; Aged; Binding Sites; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabe | 1992 |